Cardiff Oncology宣布管理层变动 公司迈入晚期临床开发阶段

美股速递
Jan 27

随着公司战略重心向晚期临床开发阶段转移,Cardiff Oncology, Inc.今日宣布对其高管团队进行重要调整。此次人事变动旨在优化组织架构,为后续关键性临床试验的推进提供更强有力的领导支持。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10